Cervical cancer screening: Which HPV test should be used - L1 or E6/E7?

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 170, Issue 1, 2013, Pages 45-46

  Tjalma, W A A ^a   Depuydt, C E ^b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b Sonic Healthcare Benelux ^*  (Belgium)

Author keywords

Cervical cancer screening; E6; E7; Failure; HPV test; Integration; L1; Missing

Indexed keywords

CAPSID PROTEIN L1; WART VIRUS VACCINE;

ARTICLE; CANCER SCREENING; CYTOLOGY; DIAGNOSTIC ACCURACY; FOLLOW UP; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; MIXED INFECTION; PERSISTENT INFECTION; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUMOR INVASION; UTERINE CERVIX CANCER; VACCINATION; VIRUS DNA CELL DNA INTERACTION; VIRUS LOAD; WART VIRUS;

CERVICAL CANCER SCREENING; E6; E7; FAILURE; HPV TEST; INTEGRATION; L1; MISSING;

CAPSID PROTEINS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MASS SCREENING; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; REPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 84883055554     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2013.06.027     Document Type: Article

References (10)

1. M.R. McCredie, K.J. Sharples, and C. Paul Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study Lancet Oncol 9 2008 425 434
2. M. Pett, and N. Coleman Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis J Pathol 212 2007 356 367
3. G. Badaracco, A. Venuti, A. Sedati, and M.L. Marcante HPV16 and HPV18 in genital tumors: significantly different levels of viral integration and correlation to tumor invasiveness J Med Virol 67 2002 574 582
4. S. Vinokurova, N. Wentzensen, and I. Kraus Type-dependent integration frequency of human papillomavirus genomes in cervical lesions Cancer Res 68 2008 307 313
5. W. Qu, G. Jiang, and Y. Cruz PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems J Clin Microbiol 35 1997 1304 1310
6. P.E. Gravitt, C.L. Peyton, and T.Q. Alessi Improved amplification of genital human papillomaviruses J Clin Microbiol 38 2000 357 361
7. C. Perrons, B. Kleter, R. Jelley, H. Jalal, W. Quint, and R. Tedder Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic J Med Virol 67 2002 246 252
8. C.E. Depuydt, G.A. Boulet, C.A. Horvath, I.H. Benoy, A.J. Vereecken, and J.J. Bogers Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types J Cell Mol Med 11 2007 881 891
9. C.E. Depuydt, A.M. Criel, I.H. Benoy, M. Arbyn, A.J. Vereecken, and J.J. Bogers Changes in type-specific human papillomavirus load predict progression to cervical cancer J Cell Mol Med 16 2012 3096 3104
10. C.C. Roberts, A.S. Tadesse, and J. Sands Detection of HPV in Norwegian cervical biopsy specimens with type-specific PCR and reverse line blot assays J Clin Virol 36 2006 277 282